General vs Spinal in Total Joint Arthroplasty (TJA)

NCT ID: NCT06747494

Last Updated: 2025-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

2396 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-01

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to compare post-operative outcomes from patients undergoing TJA. The study team wants to learn about outcomes like length of hospital stay, post-operative pain scores, post-operative nausea, deep and superficial surgical site infection, periprosthetic fracture (a broken bone that occurs around an orthopaedic implant), implant dislocation, readmission rates, and revision rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Hip Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General Anesthesia

Participants in this group will receive general anesthesia for TJA for up to 2 hours.

Group Type EXPERIMENTAL

General Anesthesia

Intervention Type PROCEDURE

Participants will receive a one-time general anesthesia dose during the total joint arthroplasty procedure as per standard of care.

Spinal Anesthesia

Participants in this group will receive spinal anesthesia for TJA for up to 2 hours.

Group Type EXPERIMENTAL

Spinal Anesthesia

Intervention Type PROCEDURE

Participants will receive a one-time spinal anesthesia dose during the total joint arthroplasty procedure as per standard of care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General Anesthesia

Participants will receive a one-time general anesthesia dose during the total joint arthroplasty procedure as per standard of care.

Intervention Type PROCEDURE

Spinal Anesthesia

Participants will receive a one-time spinal anesthesia dose during the total joint arthroplasty procedure as per standard of care.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing a primary total hip or knee arthroplasty
* Subjects must be capable of providing informed consent
* English or Spanish speaking

Exclusion Criteria

Patients with contraindications for spinal anesthesia such as:

* Prior lumbar surgery with hardware insertion
* Elevated intracranial pressure
* Infection at the site of the procedure
* Thrombocytopenia or coagulopathy
* Severe mitral and aortic stenosis and left ventricular outflow obstruction
* Severe spine pathology (spinal stenosis, spondylolisthesis, spondylosis) with radiculopathy and/or neurogenic claudication
* Preexisting neurological disease

Patients with contraindications for general anesthesia such as:

* Congestive heart failure
* Severe aortic stenosis
* Patient is unable/unwilling to consent
* Current pregnancy or women planning on becoming pregnant in the next year, and women who think they might be pregnant, or women who become pregnant during the study period will be removed from the study.
* Prisoners
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Miami

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Victor Hugo Hernandez

Professor of Clinical

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Victor H Hernandez, MD

Role: PRINCIPAL_INVESTIGATOR

University of Miami

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Miami

Miami, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Victor H Hernandez, MD

Role: CONTACT

305-689-5195

Antonio M Fernandez-Perez, MS

Role: CONTACT

305-689-5195

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Victor H Hernandez, MD

Role: primary

305-689-5195

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20240978

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparing Ankle Fusion to Ankle Replacement
NCT01620541 ACTIVE_NOT_RECRUITING